351 related articles for article (PubMed ID: 29669939)
1. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
[TBL] [Abstract][Full Text] [Related]
2. The Potential Causes of Cystic Fibrosis-Related Diabetes.
Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
[TBL] [Abstract][Full Text] [Related]
3. Islet-intrinsic effects of CFTR mutation.
Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
[TBL] [Abstract][Full Text] [Related]
4. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
Malik SS; Padmanabhan D; Hull-Meichle RL
Front Endocrinol (Lausanne); 2023; 14():1269139. PubMed ID: 38075070
[TBL] [Abstract][Full Text] [Related]
5. The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice.
Fontés G; Ghislain J; Benterki I; Zarrouki B; Trudel D; Berthiaume Y; Poitout V
Diabetes; 2015 Dec; 64(12):4112-22. PubMed ID: 26283735
[TBL] [Abstract][Full Text] [Related]
6. Short-term CFTR inhibition reduces islet area in C57BL/6 mice.
Khan D; Kelsey R; Maheshwari RR; Stone VM; Hasib A; Manderson Koivula FN; Watson A; Harkin S; Irwin N; Shaw JA; McClenaghan NH; Venglovecz V; Ébert A; Flodström-Tullberg M; White MG; Kelly C
Sci Rep; 2019 Aug; 9(1):11244. PubMed ID: 31375720
[TBL] [Abstract][Full Text] [Related]
7. CFTR Influences Beta Cell Function and Insulin Secretion Through Non-Cell Autonomous Exocrine-Derived Factors.
Sun X; Yi Y; Xie W; Liang B; Winter MC; He N; Liu X; Luo M; Yang Y; Ode KL; Uc A; Norris AW; Engelhardt JF
Endocrinology; 2017 Oct; 158(10):3325-3338. PubMed ID: 28977592
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous expression of CFTR in insulin-secreting β-cells of the normal human islet.
Di Fulvio M; Bogdani M; Velasco M; McMillen TS; Ridaura C; Kelly L; Almutairi MM; Kursan S; Sajib AA; Hiriart M; Aguilar-Bryan L
PLoS One; 2020; 15(12):e0242749. PubMed ID: 33264332
[TBL] [Abstract][Full Text] [Related]
9. Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas.
Boom A; Lybaert P; Pollet JF; Jacobs P; Jijakli H; Golstein PE; Sener A; Malaisse WJ; Beauwens R
Endocrine; 2007 Oct; 32(2):197-205. PubMed ID: 18040894
[TBL] [Abstract][Full Text] [Related]
10. Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells?
Ali BR
Med Hypotheses; 2009 Jan; 72(1):55-7. PubMed ID: 18851900
[TBL] [Abstract][Full Text] [Related]
11. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
Barrio R
Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
[TBL] [Abstract][Full Text] [Related]
12. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
13. In Situ Analysis Reveals That CFTR Is Expressed in Only a Small Minority of β-Cells in Normal Adult Human Pancreas.
White MG; Maheshwari RR; Anderson SJ; Berlinguer-Palmini R; Jones C; Richardson SJ; Rotti PG; Armour SL; Ding Y; Krasnogor N; Engelhardt JF; Gray MA; Morgan NG; Shaw JAM
J Clin Endocrinol Metab; 2020 May; 105(5):1366-74. PubMed ID: 31748811
[TBL] [Abstract][Full Text] [Related]
14. Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.
Hull RL; Gibson RL; McNamara S; Deutsch GH; Fligner CL; Frevert CW; Ramsey BW; Sanda S
Diabetes Care; 2018 Apr; 41(4):823-830. PubMed ID: 29437698
[TBL] [Abstract][Full Text] [Related]
15. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.
Olivier AK; Yi Y; Sun X; Sui H; Liang B; Hu S; Xie W; Fisher JT; Keiser NW; Lei D; Zhou W; Yan Z; Li G; Evans TI; Meyerholz DK; Wang K; Stewart ZA; Norris AW; Engelhardt JF
J Clin Invest; 2012 Oct; 122(10):3755-68. PubMed ID: 22996690
[TBL] [Abstract][Full Text] [Related]
16. CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response.
Ntimbane T; Mailhot G; Spahis S; Rabasa-Lhoret R; Kleme ML; Melloul D; Brochiero E; Berthiaume Y; Levy E
Am J Physiol Endocrinol Metab; 2016 Feb; 310(3):E200-12. PubMed ID: 26625901
[TBL] [Abstract][Full Text] [Related]
17. Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus.
Westholm E; Wendt A; Eliasson L
Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211031204. PubMed ID: 34345195
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.
Stalvey MS; Muller C; Schatz DA; Wasserfall CH; Campbell-Thompson ML; Theriaque DW; Flotte TR; Atkinson MA
Diabetes; 2006 Jul; 55(7):1939-45. PubMed ID: 16804061
[TBL] [Abstract][Full Text] [Related]
19. Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.
Bellin MD; Laguna T; Leschyshyn J; Regelmann W; Dunitz J; Billings J; Moran A
Pediatr Diabetes; 2013 Sep; 14(6):417-21. PubMed ID: 23952705
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 Is Increased by CFTR Loss of Function, Is Lowered by Insulin, and Increases In Vivo at Onset of CFRD.
Montanini L; Cirillo F; Smerieri A; Pisi G; Giardino I; d'Apolito M; Spaggiari C; Bernasconi S; Amarri S; Street ME
J Clin Endocrinol Metab; 2016 Mar; 101(3):1274-81. PubMed ID: 26760176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
